Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
8
self-reported 2–10 band
Founded
2021
5 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
2
Series unknown · Jun 2024
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
CURRUS BIOLOGICS PTY LTD.
ABN82645510194
Legal entities
Show as table · Currus Biologics Pty Ltd: 1 registry entity
| CURRUS BIOLOGICS PTY LTD. | ABN 82645510194 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Currus Biologics is utilising its proprietary BEAT technology to develop CAR-T cell therapies for the treatment of solid tumour cancers, traditionally difficult to treat with current CAR-T cell therapies.
Currus Biologics’ proprietary Bispecific Engagers of Antigen Presenting Cells and T cells (BEAT) technology overcomes many of the challenges presented when treating solid tumours with traditional CAR-T cell therapy, demonstrating CAR-T cell proliferation and persistence, CAR-T cell trafficking to the tumour and immunological memory extending to additional antigens.
Currus Biologics is a privately held biotechnology company based in Melbourne, Australia.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU31 Queen St; Melbourne, Victoria 3000Primary
Grid intelligence Members
Funding
Rounds2
Round typeSeries unknown · venture round
Amount (USD)not recorded
Stage ranknot recorded
Investors named1
Since last round1 yr 7 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2021 to 2026 |
| Series unknown · 7 Jun 2024 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Currus Biologics Pty Ltd?
One Victoria entity on the ABR: CURRUS BIOLOGICS PTY LTD. (ABN 82 645 510 194), high confidence.
How many people work at Currus Biologics Pty Ltd?
8 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Currus Biologics Pty Ltd have offices?
One address on record, Australia only. Primary: 31 Queen St, Melbourne, Victoria 3000.
Has Currus Biologics Pty Ltd raised funding?
Two rounds. Latest 7 June 2024: Series unknown, investor Brandon BioCatalyst, no amount recorded.
Which companies are listed alongside Currus Biologics Pty Ltd?
11 profiles list Currus Biologics Pty Ltd as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own. Kinoxis Therapeutics Pty Ltd and Aculeus Therapeutics list it back.